Merck (MRK) Asset Utilization Ratio (2009 - 2026)
Merck's (MRK) quarterly Asset Utilization Ratio came in at 0.52 in Q2 2026, down 5.82% year-over-year from 0.55 in Q2 2025, and up 3.98% quarter-over-quarter from 0.5 in Q1 2026.
Analysis
Merck (MRK) Asset Utilization Ratio (2009 - 2026) Analysis & Trends
Merck (MRK) has reported Asset Utilization Ratio for 18 consecutive years, with 0.52 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Asset Utilization Ratio fell 5.82% year-over-year to 0.52 in Q2 2026; TTM through Jun 2026 was 0.52, a 5.82% decrease from a year earlier, with the FY2025 full-year figure at 0.51, down 10.73% from the prior year.
- Asset Utilization Ratio was 0.52 for Q2 2026 at Merck, up from 0.5 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.58 in Q1 2024 and troughed at 0.49 in Q4 2025.
- A 5-year average of 0.54 and a median of 0.55 in 2022 frame the typical range for Asset Utilization Ratio.
- Across the five-year window, Asset Utilization Ratio rose 12.12% in 2022 and dropped 10.77% in 2025, its largest moves.
- Over 5 years, Asset Utilization Ratio stood at 0.55 in 2022, then grew by 2.75% to 0.56 in 2023, then declined by 2.92% to 0.55 in 2024, then retreated by 10.77% to 0.49 in 2025, then climbed by 5.54% to 0.52 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.52 (Q2 2026), 0.5 (Q1 2026), and 0.49 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 0.49 |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 0.47 |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 0.52 |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 0.57 |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 0.31 |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 0.56 |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 0.36 |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | - |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 0.69 |
| 10 | Incyte | 25.18 Bn | 20.65 Bn | 1.57 Bn | 0.77 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.52 |
| Mar 31, 2026 | 0.50 |
| Dec 31, 2025 | 0.49 |
| Sep 30, 2025 | 0.52 |
| Jun 30, 2025 | 0.55 |
| Mar 31, 2025 | 0.55 |
| Dec 31, 2024 | 0.55 |
| Sep 30, 2024 | 0.55 |
| Jun 30, 2024 | 0.57 |
| Mar 31, 2024 | 0.58 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.56 |
| Jun 30, 2023 | 0.55 |
| Mar 31, 2023 | 0.53 |
| Dec 31, 2022 | 0.55 |
| Sep 30, 2022 | 0.55 |
| Jun 30, 2022 | 0.53 |
| Mar 31, 2022 | 0.51 |
| Dec 31, 2021 | 0.49 |
| Sep 30, 2021 | 0.50 |